Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 1.835
-0.060 (-3.17%)
May 18, 2026, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 353.56 million as of May 18, 2026. Its market cap has decreased by -42.59% in one year.
Market Cap
353.56M
Enterprise Value
646.00M
Revenue
737.49M
Ranking
n/a
PE Ratio
13.44
Stock Price
1.84
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 353.56M, a decrease of -48.78%. That is a compound annual growth rate of -12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 353.56M | -32.65% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.09B |
| Integral Diagnostics | 785.95M |
| Monash IVF Group | 278.59M |
| Healius | 257.78M |
| Rhythm Biosciences | 50.43M |
| Cryosite | 48.81M |
| Microba Life Sciences | 46.89M |
| INOVIQ | 45.05M |